The Cancer Plan 2014-2019
Last updated: 05/10/2015
The third Cancer Plan has been launched by the French President François Hollande in February 2014. It aims to rise to both human and societal challenges issued by cancer.
Four priorities and 17 operational objectives
The primary aim of the Cancer Plan is to cure more patients by promoting early diagnosis and guaranteeing access for all to quality medicine and innovations. Apart from improving care and medical practices, the Cancer Plan proposes the comprehensive care of the patient, taking into account the totality of his/her needs to maintain the continuity and quality of life during and after the illness.
Cancers are also the leading cause of avoidable deaths. Based on current knowledge, it is estimated that nearly one in two cancer deaths could be avoided. Thus, the Plan is investing in prevention to significantly reduce the number of new cancer cases. Finally, it supports basic research as a source of future advances.
An additional aim is to optimise management and arrangements related to combating cancer, for better efficiency, with full involvement of patients and users of the health system.
The Plan, which comprises 17 operational objectives, is part of the implementation of the National Health Strategy and the Strategic Agenda for Research, Technology Transfer and Innovation, “France-Europe 2020.”
Governance of the Plan
The Cancer Plan’s management shall be provided by a committee co-chaired by the Ministers for Research and Health. This is composed of central administrative directors of the Ministries for Research and Health and of other ministries involved, the chief executive officer of the French National Health Insurance Fund, the chairperson of the French National Cancer Institute, and associations representing patients and users of the health system.
It reports on implementation of the Plan to the Interministerial Health Committee, under the aegis of the Prime Minister, and submits its annual report to the President of France.
The French National Cancer Institute coordinates monitoring of the Plan and measurement of its results on behalf of the steering committee. It organizes consultation on implementation with the players and users, in cooperation with the steering committee, at annual seminars.
The regional health agencies (ARS) are responsible for the implementation of the Cancer Plan in their region. They organise consultation with the Regional Conference on Health and Autonomy (CRSA) and the territorial conferences.